Published in Facts Views Vis Obgyn on January 01, 2010
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
The arrogance of preventive medicine. CMAJ (2002) 5.83
Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med (1975) 5.33
Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med (1996) 3.35
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol (2009) 3.33
Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) (2006) 2.77
Breast cancer and hormone-replacement therapy: up to general practice to pick up the pieces. Lancet (2003) 2.66
Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer (2005) 2.32
From presumed benefit to potential harm--hormone therapy and heart disease. N Engl J Med (2003) 1.89
Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol (1981) 1.36
Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis. Fertil Steril (2005) 1.19